首页> 外文期刊>Comptes Rendus de l'Academie Bulgare des Sciences: Sciences Mathematiques et Naturelles >IMMUNOMODULATORY EFFECTS OF HUMAN BONE MARROW OR ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELLS ON T-HELPER CELL CYTOKINE PRODUCTION IN VITRO
【24h】

IMMUNOMODULATORY EFFECTS OF HUMAN BONE MARROW OR ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELLS ON T-HELPER CELL CYTOKINE PRODUCTION IN VITRO

机译:人体骨髓或脂肪组织来源的间充质干细胞对T型干细胞细胞因子体外生产的免疫调节作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Mesenchymal stem cells (MSC) have been characterized as multipotent cells which are able to differentiate into several mesodermal and nonmesodermal lineage cells and this feature along with their extensive growth and comprehensive immunomodulatory properties establish them as a promising tool for therapeutic applications. Although bone marrow (BM) is the most common MSC source, cells with similar characteristics have been shown to be present in several others adult tissues. Adipose tissue (AT), large quantities from which could be easily attained, represents an attractive alternative to BM in isolating adipose tissue-derived MSC (AT-MSC). BM-MSCs and AT-MSCs share some immunomodulatory properties as they are both not inherently immunogenic and suppress the proliferation of alloantigen- or mitogen-stimulated T-cells. Our purpose was to comparatively examine the ability of BM-MSCs and AT-MSCs to suppress the cytokine production by mitogen-stimulated Th-1- and Th-2-cells. MSCs and peripheral blood mononuclear cells (PBMCs) were cocultured in the presence of phytohaemagglutinin (PHA) and as a result an inhibition of T-cell cytokine (IFN-gamma and IL-4) production was observed. These results further support the potential therapeutic use of hMSCs in immune-mediated disorders.
机译:间充质干细胞(MSC)已被表征为能够分化为几种中胚层和非中胚层谱系细胞的多能细胞,这一特征以及它们的广泛生长和全面的免疫调节特性使它们成为治疗应用的有前途的工具。尽管骨髓(BM)是最常见的MSC来源,但已证明具有相似特征的细胞存在于其他几种成人组织中。在分离脂肪组织衍生的MSC(AT-MSC)方面,很容易获得大量的脂肪组织(AT),是BM的有吸引力的替代方案。 BM-MSC和AT-MSC具有一些免疫调节特性,因为它们既不是固有的免疫原性,又可以抑制同种抗原或促细胞分裂剂刺激的T细胞的增殖。我们的目的是比较检查BM-MSC和AT-MSC抑制有丝分裂原刺激的Th-1-和Th-2-细胞产生细胞因子的能力。在存在植物血凝素(PHA)的情况下,将MSC和外周血单核细胞(PBMC)共培养,结果观察到对T细胞细胞因子(IFN-γ和IL-4)产生的抑制作用。这些结果进一步支持了hMSC在免疫介导的疾病中的潜在治疗用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号